Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1292)
IONIS PHARMACEUTICALS INC (IONS)
Swayze Eric — EVP Research
Shares
10,602
Price
$79.18
Total Value
$839.49K
Shares Held After
21,759
% of Holdings
32.8%
Krystal Biotech, Inc. (KRYS)
Thomas John Charles — EVP, General Counsel
Shares
1,000
Price
$347.27
Total Value
$347.27K
Shares Held After
0
% of Holdings
100.0%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
28,716
Price
$50.02
Total Value
$1.44M
Shares Held After
519,227
% of Holdings
5.2%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
100
Price
$87.00
Total Value
$8.70K
Shares Held After
60,137
% of Holdings
0.2%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
11,337
Price
$86.51
Total Value
$980.76K
Shares Held After
60,137
% of Holdings
15.9%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
8,522
Price
$85.26
Total Value
$726.59K
Shares Held After
71,474
% of Holdings
10.7%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
419
Price
$86.39
Total Value
$36.20K
Shares Held After
60,137
% of Holdings
0.7%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
582
Price
$85.24
Total Value
$49.61K
Shares Held After
60,556
% of Holdings
1.0%
Definium Therapeutics, Inc. (DFTX)
Barrow Robert — Director
Shares
29,208
Price
$45.03
Total Value
$1.32M
Shares Held After
1,098,246
% of Holdings
2.6%
Definium Therapeutics, Inc. (DFTX)
Roberts Brandi — Chief Financial Officer
Shares
3,013
Price
$45.03
Total Value
$135.68K
Shares Held After
209,487
% of Holdings
1.4%
Definium Therapeutics, Inc. (DFTX)
Sullivan Mark — Chief Legal Officer
Shares
13,008
Price
$45.03
Total Value
$585.75K
Shares Held After
320,571
% of Holdings
3.9%
Greenland Mines Ltd (GRML)
El-Dada Riad Hussein — Director
Shares
175,000
Price
$0.23
Total Value
$40.55K
Shares Held After
175,000
% of Holdings
50.0%
Definium Therapeutics, Inc. (DFTX)
Wiley Matthew T. — Chief Commercial Officer
Shares
2,867
Price
$45.03
Total Value
$129.10K
Shares Held After
174,633
% of Holdings
1.6%
Definium Therapeutics, Inc. (DFTX)
Karlin Daniel — Chief Medical Officer
Shares
10,035
Price
$45.03
Total Value
$451.88K
Shares Held After
503,282
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$554.84
Total Value
$133.16K
Shares Held After
40,513
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
800
Price
$553.97
Total Value
$443.17K
Shares Held After
40,753
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,778
Price
$552.68
Total Value
$982.67K
Shares Held After
41,553
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,814
Price
$551.61
Total Value
$1.00M
Shares Held After
43,331
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,617
Price
$550.86
Total Value
$890.75K
Shares Held After
45,145
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
762
Price
$549.55
Total Value
$418.76K
Shares Held After
46,762
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
645
Price
$548.77
Total Value
$353.96K
Shares Held After
47,524
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
441
Price
$547.87
Total Value
$241.61K
Shares Held After
48,169
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
301
Price
$546.38
Total Value
$164.46K
Shares Held After
48,610
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
418
Price
$545.08
Total Value
$227.84K
Shares Held After
48,911
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
684
Price
$543.54
Total Value
$371.78K
Shares Held After
49,329
% of Holdings
1.4%
INSMED Inc (INSM)
Lewis William — Director
Shares
1,292
Price
$106.27
Total Value
$137.30K
Shares Held After
258,917
% of Holdings
0.5%
INSMED Inc (INSM)
Lewis William — Director
Shares
2,456
Price
$105.27
Total Value
$258.54K
Shares Held After
260,209
% of Holdings
0.9%
INSMED Inc (INSM)
Lewis William — Director
Shares
3,723
Price
$104.28
Total Value
$388.23K
Shares Held After
262,665
% of Holdings
1.4%
INSMED Inc (INSM)
Lewis William — Director
Shares
1,836
Price
$103.10
Total Value
$189.29K
Shares Held After
266,388
% of Holdings
0.7%
INSMED Inc (INSM)
Lewis William — Director
Shares
12,091
Price
$102.34
Total Value
$1.24M
Shares Held After
268,224
% of Holdings
4.3%
Dyne Therapeutics, Inc. (DYN)
Lucera Erick — Chief Financial Officer
Shares
2,362
Price
$20.37
Total Value
$48.11K
Shares Held After
121,563
% of Holdings
1.9%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
5,019
Price
$21.10
Total Value
$105.90K
Shares Held After
1,081,044
% of Holdings
0.5%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
6,382
Price
$21.10
Total Value
$134.66K
Shares Held After
1,478,378
% of Holdings
0.4%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
12,699
Price
$21.10
Total Value
$267.95K
Shares Held After
4,742,410
% of Holdings
0.3%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
15,778
Price
$11.00
Total Value
$173.56K
Shares Held After
110,180
% of Holdings
12.5%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
4,222
Price
$11.00
Total Value
$46.44K
Shares Held After
125,958
% of Holdings
3.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,646
Price
$118.60
Total Value
$313.82K
Shares Held After
564,668
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
3,359
Price
$117.50
Total Value
$394.68K
Shares Held After
567,314
% of Holdings
0.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
11,375
Price
$116.53
Total Value
$1.33M
Shares Held After
570,673
% of Holdings
2.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
8,389
Price
$115.57
Total Value
$969.52K
Shares Held After
582,048
% of Holdings
1.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,289
Price
$114.65
Total Value
$147.78K
Shares Held After
590,437
% of Holdings
0.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,437
Price
$113.70
Total Value
$163.39K
Shares Held After
591,726
% of Holdings
0.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
100
Price
$111.89
Total Value
$11.19K
Shares Held After
593,163
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
86
Price
$110.79
Total Value
$9.53K
Shares Held After
593,263
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
265
Price
$110.30
Total Value
$29.23K
Shares Held After
593,349
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,011
Price
$108.83
Total Value
$218.86K
Shares Held After
593,614
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
46
Price
$129.61
Total Value
$5.96K
Shares Held After
529,718
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
23
Price
$108.02
Total Value
$2.48K
Shares Held After
595,625
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
305
Price
$128.69
Total Value
$39.25K
Shares Held After
529,764
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,399
Price
$107.30
Total Value
$150.11K
Shares Held After
595,648
% of Holdings
0.2%
Showing 401–450 of 1292 transactions (page 9 of 26)